Conclusions—Clinical evidence is lacking for the association of glycemic control with implant
failure while support is emerging for implant therapy in diabetes patients with appropriate
accommodations for delays in implant integration based on glycemic control. The role for
implants to improve oral function in diabetes management and the effects of hyperglycemia on
implant integration remains to be determined